Abstract
Purpose
To investigate the longitudinal associations between demographic, clinical and lifestyle factors, and changes in patient-reported outcomes (PROs) in cancer survivors 6–9 years post-diagnosis in Western Australia.
Methods
A total of 290 individuals participated in this study. Three-quarters of participants were female, and 55%, 31%, and 14% were survivors of breast cancer, colon cancer, and non-Hodgkin lymphoma (NHL), respectively. PROs (fatigue, depression, and health-related quality of life (HRQOL)) were reported at two time points (2012–13 and 2017). Descriptive statistics were used to assess the overall changes over time and linear mixed models were used to identify factors associated with changes over time, after adjusting for confounders.
Results
No significant changes were observed in PROs between time point 1 and follow-up at the population level, yet a notable proportion of participants (23% for fatigue, 10% for depression, and 39% for HRQOL) reported a negative minimal clinically important difference (MCID). Being non-Caucasian and having had NHL were associated with negative changes over time. Being obese and having had radiotherapy were related to improved outcomes.
Conclusion
Cancer survivors whose levels of fatigue, depression, and quality of life are compromised during cancer treatment may require intervention even 6–9 years post-treatment. Our results suggest particular attention should be paid to those who are non-Caucasian and who have had NHL. This is crucial for providing appropriate care and to support those who are at increased risk of deteriorating naturally over time.
Similar content being viewed by others
Data availability
The syntax used to run the analysis reported in this manuscript is available from the corresponding author on reasonable request. The dataset cannot be shared due to ethical approval constraints.
References
Australian Institute of Health and Welfare (2020) Cancer data in Australia. AIHW. https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia. Accessed 27 Nov 2020
Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, Micheli A, Lillini R, Francisci S (2015) Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: results of EUROCARE-5, a population-based study. Eur J Cancer 51(15):2120–2129. https://doi.org/10.1016/j.ejca.2015.07.025
Howlader N, Noone A, Krapcho M, Miller D, Brest A, Yu M (2020) SEER Cancer statistics review, 1975–2017. National Cancer Institute Bethesda, MD
American Cancer Society (2020) Cancer facts and figures 2020. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html. Accessed 27 Nov 2020
Lagergren P, Schandl A, Aaronson NK, Adami HO, de Lorenzo F, Denis L, Faithfull S, Liu L, Meunier F, Ulrich C (2019) Cancer survivorship: an integral part of Europe’s research agenda. Mol Oncol 13(3):624–635
Gegechkori N, Haines L, Lin JJ (2017) Long-term and latent side effects of specific cancer types. Med Clin North Am 101(6):1053–1073. https://doi.org/10.1016/j.mcna.2017.06.003
Roila F, Fumi G, Ruggeri B, Antonuzzo A, Ripamonti C, Fatigoni S, Cavanna L, Gori S, Fabi A, Marzano N (2019) Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO). Support Care Cancer 27(3):1041–1047
Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, McCready DR, Wong RK, Jiang H, Howell D (2016) Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv 10(1):51–61
Abrahams H, Gielissen M, Schmits I, Verhagen C, Rovers M, Knoop H (2016) Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol 27(6):965–974
Bower JE (2014) Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11(10):597–609
Brandenbarg D, Maass S, Geerse OP, Stegmann ME, Handberg C, Schroevers MJ, Duijts SFA (2019) A systematic review on the prevalence of symptoms of depression, anxiety and distress in long-term cancer survivors: implications for primary care. Eur J Cancer Care 28(3):e13086. https://doi.org/10.1111/ecc.13086
Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ (2019) Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer 19(1):943. https://doi.org/10.1186/s12885-019-6181-4
Götze H, Friedrich M, Taubenheim S, Dietz A, Lordick F, Mehnert A (2020) Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support Care Cancer 28(1):211–220
Schlesinger S, Walter J, Hampe J, von Schönfels W, Hinz S, Küchler T, Jacobs G, Schafmayer C, Nöthlings U (2014) Lifestyle factors and health-related quality of life in colorectal cancer survivors. Cancer Causes Control 25(1):99–110
Jansen L, Koch L, Brenner H, Arndt V (2010) Quality of life among long-term (⩾5 years) colorectal cancer survivors - systematic review. Eur J Cancer 46(16):2879–2888. https://doi.org/10.1016/j.ejca.2010.06.010
Mehra K, Berkowitz A, Sanft T (2017) Diet, physical activity, and body weight in cancer survivorship. Med Clin N Am 101(6):1151–1165. https://doi.org/10.1016/j.mcna.2017.06.004
Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H (2017) Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol 56(2):190–197
Koch L, Jansen L, Herrmann A, Stegmaier C, Holleczek B, Singer S, Brenner H, Arndt V (2013) Quality of life in long-term breast cancer survivors–a 10-year longitudinal population-based study. Acta Oncol 52(6):1119–1128
Boyle T, Vallance JK, Ransom EK, Lynch BM (2016) How sedentary and physically active are breast cancer survivors, and which population subgroups have higher or lower levels of these behaviors? Support Care Cancer 24(5):2181–2190. https://doi.org/10.1007/s00520-015-3011-3
Lynch BM, Boyle T, Winkler E, Occleston J, Courneya KS, Vallance JK (2016) Patterns and correlates of accelerometer-assessed physical activity and sedentary time among colon cancer survivors. Cancer Causes Control : CCC 27(1):59–68. https://doi.org/10.1007/s10552-015-0683-4
Boyle T, Lynch BM, Ransom EK, Vallance JK (2017) Volume and correlates of objectively measured physical activity and sedentary time in non-Hodgkin lymphoma survivors. Psycho-oncology 26(2):239–247. https://doi.org/10.1002/pon.4027
Australian Bureau of Statistics (2018) Census of population and housing: socio-economic indexes for areas (SEIFA), Australia, 2016. https://www.abs.gov.au/ausstats/abs@.nsf/mf/2033.0.55.001. Accessed 12 Aug 2019
Department of Health and Aged Care (2001) Measuring remoteness: accessibility/remoteness index of Australia (ARIA). https://www1.health.gov.au/internet/main/publishing.nsf/Content/health-historicpubs-hfsocc-ocpanew14a.htm. Accessed 28 Aug 2019
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13(2):63–74. https://doi.org/10.1016/s0885-3924(96)00274-6
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579
Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1(79):79
Cella D, Eton DT, Lai J-S, Peterman AH, Merkel DE (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manag 24(6):547–561. https://doi.org/10.1016/S0885-3924(02)00529-8
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Löwe B, Unützer J, Callahan CM, Perkins AJ, Kroenke K (2004) Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Med Care 42(12):1194–1201
Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl 2):13–19
Pearman T, Yanez B, Peipert J, Wortman K, Beaumont J, Cella D (2014) Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer 120(18):2902–2909. https://doi.org/10.1002/cncr.28758
Westreich D, Greenland S (2013) The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol 177(4):292–298. https://doi.org/10.1093/aje/kws412
Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR (2019) Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc 16(1):22–28
Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition. National Academies Press
Schoormans D, Czene K, Hall P, Brandberg Y (2015) The impact of co-morbidity on health-related quality of life in breast cancer survivors and controls. Acta Oncol 54(5):727–734
Rodriguez JL, Hawkins NA, Berkowitz Z, Li C (2015) Factors associated with health-related quality of life among colorectal cancer survivors. Am J Prev Med 49(6):S518–S527
Butow PN, Bell ML, Aldridge L, Sze M, Eisenbruch M, Jefford M, Schofield P, Girgis A, King M, Duggal P (2013) Unmet needs in immigrant cancer survivors: a cross-sectional population-based study. Support Care Cancer 21(9):2509–2520
Bouskill K, Kramer M (2016) The impact of cancer and quality of life among long-term survivors of breast cancer in Austria. Support Care Cancer 24(11):4705–4712
Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB (2010) Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer 116(24):5740–5748
Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fosså SD (2010) Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv 4(4):405–414
Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 10(4):407–415
Nekhlyudov L, Ganz PA, Arora NK, Rowland JH (2017) Going beyond being lost in transition: a decade of progress in cancer survivorship. J Clin Oncol 35(18):1978–1981. https://doi.org/10.1200/JCO.2016.72.1373
Acknowledgements
The authors are grateful to the participants of the study.
Code availability
Not applicable.
Funding
This work was supported by the Breast Cancer Research Centre-Western Australia (grant to TB, BML, and JKV), Cancer Council Western Australia (grant to TB, BML, and JKV; award to TB), and Curtin University (funding to TB). BML is supported by a Mid-Career Fellowship (MCRF18005) from the Victorian Cancer Agency.
Author information
Authors and Affiliations
Contributions
SRK was involved in the conception and design, analyses and interpretation of data, drafting, revising, and final approval of the article. KG was involved in the conception and design, interpretation of data, and drafting, revising, and final approval of the article. IM was involved in interpretation of data and drafting, revising, and final approval of the article. BML was involved in the material preparation, data collection, interpretation of data, revising, and final approval of the article. JKV was involved in the material preparation, data collection, interpretation of data, revising, and final approval of the article. TB was involved in the material preparation, data collection, conception and design, analysis and interpretation of data, drafting, revising, and final approval of the article.
Corresponding author
Ethics declarations
Ethics approval
The baseline and follow-up study was approved by the Human Research Ethics Committees at the Western Australian Department of Health, The University of Western Australia, Curtin University, and the University of South Australia.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 216 kb)
Rights and permissions
About this article
Cite this article
van der Kruk, S.R., Gunn, K.M., Mesters, I. et al. Associations between baseline demographic, clinical and lifestyle factors, and changes in fatigue, depression, and health-related quality of life in long-term cancer survivors: a cohort study. Support Care Cancer 29, 4711–4722 (2021). https://doi.org/10.1007/s00520-021-06015-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06015-0